Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HNF1α maintains pancreatic α and β cell functions in primary human islets
Mollie F. Qian, Romina J. Bevacqua, Vy M.N. Coykendall, Xiong Liu, Weichen Zhao, Charles A. Chang, Xueying Gu, Xiao-Qing Dai, Patrick E. MacDonald, Seung K. Kim
Mollie F. Qian, Romina J. Bevacqua, Vy M.N. Coykendall, Xiong Liu, Weichen Zhao, Charles A. Chang, Xueying Gu, Xiao-Qing Dai, Patrick E. MacDonald, Seung K. Kim
View: Text | PDF
Research Article Endocrinology Genetics

HNF1α maintains pancreatic α and β cell functions in primary human islets

  • Text
  • PDF
Abstract

HNF1A haploinsufficiency underlies the most common form of human monogenic diabetes (HNF1A–maturity onset diabetes of the young [HNF1A-MODY]), and hypomorphic HNF1A variants confer type 2 diabetes risk. But a lack of experimental systems for interrogating mature human islets has limited our understanding of how the transcription factor HNF1α regulates adult islet function. Here, we combined conditional genetic targeting in human islet cells, RNA-Seq, chromatin mapping with cleavage under targets and release using nuclease (CUT&RUN), and transplantation-based assays to determine HNF1α-regulated mechanisms in adult human pancreatic α and β cells. Short hairpin RNA–mediated (shRNA-mediated) suppression of HNF1A in primary human pseudoislets led to blunted insulin output and dysregulated glucagon secretion after transplantation in mice, recapitulating phenotypes observed in patients with diabetes. These deficits corresponded with altered expression of genes encoding factors critical for hormone secretion, including calcium channel subunits, ATPase transporters, and extracellular matrix constituents. Additionally, HNF1A loss led to upregulation of transcriptional repressors, providing evidence for a mechanism of transcriptional derepression through HNF1α. CUT&RUN mapping of HNF1α DNA binding sites in primary human islets imputed a subset of HNF1α-regulated genes as direct targets. These data elucidate mechanistic links between HNF1A loss and diabetic phenotypes in mature human α and β cells.

Authors

Mollie F. Qian, Romina J. Bevacqua, Vy M.N. Coykendall, Xiong Liu, Weichen Zhao, Charles A. Chang, Xueying Gu, Xiao-Qing Dai, Patrick E. MacDonald, Seung K. Kim

×

Figure 1

shRNA-mediated KD of HNF1A in primary human islets.

Options: View larger image (or click on image) Download as PowerPoint
shRNA-mediated KD of HNF1A in primary human islets.
(A) Formation of pse...
(A) Formation of pseudoislets for downstream assays; transduction with lentivirus, followed by reaggregation over 5 days in culture. (B) Schematic of lentiviral constructs coding for shRNA and a GFP reporter (tGFP). Control-shRNA, nontargeting (“control”); HNF1A-shRNA, HNF1A-targeting (“HNF1AKD”). (C and D) Blue light (488 nm) images of human control (C) and HNF1AKD (D) pseudoislets. Scale bars: 1,000 μm. (E and F) mRNA expression of HNF1A (E) and putative HNF1α (F) targets in HNF1AKD relative to control pseudoislets; statistics performed on ΔCT values (n = 4–8 donors per gene). (G) Western blot analysis of HNF1α protein expression in control (CTL) and HNF1AKD (KD) pseudoislets (n = 3). (H) Quantification of blot intensities normalized to the housekeeping gene β-actin (ACTB). Data are presented as mean values ± SEM. Two-tailed t tests were used to generate P values; *P < 0.05, **P < 0.01, ***P < 0.00001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts